Translational Andrology and Urology

Translational Andrology and Urology (Transl Androl Urol, ISSN: 2223-4683) is a peer-reviewed, open-access journal dedicated to advancing the clinical and scientific understanding of male reproductive health, genitourinary disorders, and urological diseases. The journal’s scope encompasses a broad spectrum of topics within andrology and urology, including male infertility, erectile dysfunction, prostate cancer, benign prostatic hyperplasia, urinary tract infections, and emerging therapies in reproductive medicine and surgical urology. It publishes a variety of article types, including original research articles, comprehensive reviews, systematic reviews and meta-analyses, case reports, editorials, and surgical technique descriptions, with a particular emphasis on translational studies that bridge laboratory discoveries with clinical practice. The primary target audience comprises urologists, andrologists, reproductive biologists, clinical researchers, and allied healthcare professionals seeking current, evidence-based insights into patient care and disease management. Published by AME Publishing Company, the journal is fully open access, ensuring that all content is freely available to readers worldwide, which enhances the dissemination and impact of its research. As of 2026, the journal holds an Impact Factor of 1.9000 and is ranked in JCR Quartile Q3 within the subject area of Urology & Nephrology (4区医学). While positioned in the third quartile, Translational Andrology and Urology serves as a valuable platform for specialized research and clinical updates in its field, offering a focused venue for studies that may not reach the highest-tier journals but contribute meaningfully to the advancement of andrology and urology practice.